The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making

SUMMARY Objectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current medical research and opinion 2004, Vol.20 (S1), p.S5-S26
Hauptverfasser: Palmer, Andrew J., Roze, Stéphane, Valentine, William J., Minshall, Michael E., Foos, Volker, Lurati, Francesco M., Lammert, Morten, Spinas, Giatgen A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S26
container_issue S1
container_start_page S5
container_title Current medical research and opinion
container_volume 20
creator Palmer, Andrew J.
Roze, Stéphane
Valentine, William J.
Minshall, Michael E.
Foos, Volker
Lurati, Francesco M.
Lammert, Morten
Spinas, Giatgen A.
description SUMMARY Objectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated. Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in state, and diabetes type-dependent probabilities derived from published sources. Analyses can be performed on cohorts with type 1 or type 2 diabetes. Cohorts, defined in terms of age, gender, baseline risk factors and pre-existing complications, can be modified or new cohorts defined by the user. Economic and clinical data in the model can be edited, thus ensuring adaptability by allowing the inclusion of new data as they become available; creation of country- or provider-specific versions of the model; and allowing the investigation of new hypotheses. Conclusions: The CORE Diabetes Model allows the calculation of long-term outcomes, based on the best data currently available. Diabetes management strategies can be compared in different patient populations in a variety of realistic clinical settings, allowing the identification of efficient diabetes management strategies.
doi_str_mv 10.1185/030079904X1980
format Article
fullrecord <record><control><sourceid>informahealthcare_cross</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1185_030079904X1980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1185_030079904X1980</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2494-ffedcb920bd7d3dffc1cdf89b99139e3e21ce72a830b5fbb5b2323cf74256f9a3</originalsourceid><addsrcrecordid>eNp1kU9v1DAQxS0EEkvLlbOPIJHWfxISc0NpoZW22qpdJG6R7Yy7Xhx7ZTtF-w35WHhbJOihp5nR0--9GQ1C7yg5obRrTgknpBWC1D-o6MgLtKB1y6u6a9uXaHEQq6I2r9GblLaEUNYJsUC_1xvA_ermHJ9ZqSBDwldhBPcZX8ewBZ2tv8PL4O-qDHHCvbPeaunwas46TJA-4j6knLD040MHxhyge_CQEg4GX_oCljHb4BO2_r8ccM7mOeH36_2uzPTBhH3AOeDbebcLMf_LO0g3YCc1xwRTscNnoG0qptUkf5Ylj9ErI12Ct3_rEfr-9XzdX1TL1bfL_suy0qwWdVXWG7USjKixHflojKZ6NJ1QQlAugAOjGlomO05UY5RqFOOMa9PWrPlkhORH6OTRV8eQUgQz7KKdZNwPlAyHPwxP_1AA8QhYb0Kc5K8Q3ThkuXchmih9uWLgz7LdE3YD0uWNlhGGbZijL4c-F_sHqVKjhA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making</title><source>Taylor &amp; Francis</source><source>Taylor &amp; Francis Medical Library - CRKN</source><creator>Palmer, Andrew J. ; Roze, Stéphane ; Valentine, William J. ; Minshall, Michael E. ; Foos, Volker ; Lurati, Francesco M. ; Lammert, Morten ; Spinas, Giatgen A.</creator><creatorcontrib>Palmer, Andrew J. ; Roze, Stéphane ; Valentine, William J. ; Minshall, Michael E. ; Foos, Volker ; Lurati, Francesco M. ; Lammert, Morten ; Spinas, Giatgen A.</creatorcontrib><description>SUMMARY Objectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated. Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in state, and diabetes type-dependent probabilities derived from published sources. Analyses can be performed on cohorts with type 1 or type 2 diabetes. Cohorts, defined in terms of age, gender, baseline risk factors and pre-existing complications, can be modified or new cohorts defined by the user. Economic and clinical data in the model can be edited, thus ensuring adaptability by allowing the inclusion of new data as they become available; creation of country- or provider-specific versions of the model; and allowing the investigation of new hypotheses. Conclusions: The CORE Diabetes Model allows the calculation of long-term outcomes, based on the best data currently available. Diabetes management strategies can be compared in different patient populations in a variety of realistic clinical settings, allowing the identification of efficient diabetes management strategies.</description><identifier>ISSN: 0300-7995</identifier><identifier>EISSN: 1473-4877</identifier><identifier>DOI: 10.1185/030079904X1980</identifier><language>eng</language><publisher>Informa UK Ltd</publisher><subject>Complications ; Cost-effectiveness ; Costs ; Diabetes ; Health economics ; Modelling</subject><ispartof>Current medical research and opinion, 2004, Vol.20 (S1), p.S5-S26</ispartof><rights>2004 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2494-ffedcb920bd7d3dffc1cdf89b99139e3e21ce72a830b5fbb5b2323cf74256f9a3</citedby><cites>FETCH-LOGICAL-c2494-ffedcb920bd7d3dffc1cdf89b99139e3e21ce72a830b5fbb5b2323cf74256f9a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1185/030079904X1980$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1185/030079904X1980$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,4010,27900,27901,27902,59620,59726,60409,60515,61194,61229,61375,61410</link.rule.ids></links><search><creatorcontrib>Palmer, Andrew J.</creatorcontrib><creatorcontrib>Roze, Stéphane</creatorcontrib><creatorcontrib>Valentine, William J.</creatorcontrib><creatorcontrib>Minshall, Michael E.</creatorcontrib><creatorcontrib>Foos, Volker</creatorcontrib><creatorcontrib>Lurati, Francesco M.</creatorcontrib><creatorcontrib>Lammert, Morten</creatorcontrib><creatorcontrib>Spinas, Giatgen A.</creatorcontrib><title>The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making</title><title>Current medical research and opinion</title><description>SUMMARY Objectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated. Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in state, and diabetes type-dependent probabilities derived from published sources. Analyses can be performed on cohorts with type 1 or type 2 diabetes. Cohorts, defined in terms of age, gender, baseline risk factors and pre-existing complications, can be modified or new cohorts defined by the user. Economic and clinical data in the model can be edited, thus ensuring adaptability by allowing the inclusion of new data as they become available; creation of country- or provider-specific versions of the model; and allowing the investigation of new hypotheses. Conclusions: The CORE Diabetes Model allows the calculation of long-term outcomes, based on the best data currently available. Diabetes management strategies can be compared in different patient populations in a variety of realistic clinical settings, allowing the identification of efficient diabetes management strategies.</description><subject>Complications</subject><subject>Cost-effectiveness</subject><subject>Costs</subject><subject>Diabetes</subject><subject>Health economics</subject><subject>Modelling</subject><issn>0300-7995</issn><issn>1473-4877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNp1kU9v1DAQxS0EEkvLlbOPIJHWfxISc0NpoZW22qpdJG6R7Yy7Xhx7ZTtF-w35WHhbJOihp5nR0--9GQ1C7yg5obRrTgknpBWC1D-o6MgLtKB1y6u6a9uXaHEQq6I2r9GblLaEUNYJsUC_1xvA_ermHJ9ZqSBDwldhBPcZX8ewBZ2tv8PL4O-qDHHCvbPeaunwas46TJA-4j6knLD040MHxhyge_CQEg4GX_oCljHb4BO2_r8ccM7mOeH36_2uzPTBhH3AOeDbebcLMf_LO0g3YCc1xwRTscNnoG0qptUkf5Ylj9ErI12Ct3_rEfr-9XzdX1TL1bfL_suy0qwWdVXWG7USjKixHflojKZ6NJ1QQlAugAOjGlomO05UY5RqFOOMa9PWrPlkhORH6OTRV8eQUgQz7KKdZNwPlAyHPwxP_1AA8QhYb0Kc5K8Q3ThkuXchmih9uWLgz7LdE3YD0uWNlhGGbZijL4c-F_sHqVKjhA</recordid><startdate>2004</startdate><enddate>2004</enddate><creator>Palmer, Andrew J.</creator><creator>Roze, Stéphane</creator><creator>Valentine, William J.</creator><creator>Minshall, Michael E.</creator><creator>Foos, Volker</creator><creator>Lurati, Francesco M.</creator><creator>Lammert, Morten</creator><creator>Spinas, Giatgen A.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2004</creationdate><title>The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making</title><author>Palmer, Andrew J. ; Roze, Stéphane ; Valentine, William J. ; Minshall, Michael E. ; Foos, Volker ; Lurati, Francesco M. ; Lammert, Morten ; Spinas, Giatgen A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2494-ffedcb920bd7d3dffc1cdf89b99139e3e21ce72a830b5fbb5b2323cf74256f9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Complications</topic><topic>Cost-effectiveness</topic><topic>Costs</topic><topic>Diabetes</topic><topic>Health economics</topic><topic>Modelling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palmer, Andrew J.</creatorcontrib><creatorcontrib>Roze, Stéphane</creatorcontrib><creatorcontrib>Valentine, William J.</creatorcontrib><creatorcontrib>Minshall, Michael E.</creatorcontrib><creatorcontrib>Foos, Volker</creatorcontrib><creatorcontrib>Lurati, Francesco M.</creatorcontrib><creatorcontrib>Lammert, Morten</creatorcontrib><creatorcontrib>Spinas, Giatgen A.</creatorcontrib><collection>CrossRef</collection><jtitle>Current medical research and opinion</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palmer, Andrew J.</au><au>Roze, Stéphane</au><au>Valentine, William J.</au><au>Minshall, Michael E.</au><au>Foos, Volker</au><au>Lurati, Francesco M.</au><au>Lammert, Morten</au><au>Spinas, Giatgen A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making</atitle><jtitle>Current medical research and opinion</jtitle><date>2004</date><risdate>2004</risdate><volume>20</volume><issue>S1</issue><spage>S5</spage><epage>S26</epage><pages>S5-S26</pages><issn>0300-7995</issn><eissn>1473-4877</eissn><abstract>SUMMARY Objectives: We have developed an Internet-based, interactive computer model to determine the longterm health outcomes and economic consequences of implementing different treatment policies or interventions in type 1 and type 2 diabetes mellitus. The model projects outcomes for populations, taking into account baseline cohort characteristics and past history of complications, current and future diabetes management and concomitant medications, screening strategies and changes in physiological parameters over time. The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated. Methods: The model is based on a series of sub-models that simulate important complications of diabetes (cardiovascular disease, eye disease, hypoglycaemia, nephropathy, neuropathy, foot ulcer, amputation, stroke, ketoacidosis, lactic acidosis and mortality). Each sub-model is a Markov model using Monte Carlo simulation incorporating time, state, time-in state, and diabetes type-dependent probabilities derived from published sources. Analyses can be performed on cohorts with type 1 or type 2 diabetes. Cohorts, defined in terms of age, gender, baseline risk factors and pre-existing complications, can be modified or new cohorts defined by the user. Economic and clinical data in the model can be edited, thus ensuring adaptability by allowing the inclusion of new data as they become available; creation of country- or provider-specific versions of the model; and allowing the investigation of new hypotheses. Conclusions: The CORE Diabetes Model allows the calculation of long-term outcomes, based on the best data currently available. Diabetes management strategies can be compared in different patient populations in a variety of realistic clinical settings, allowing the identification of efficient diabetes management strategies.</abstract><pub>Informa UK Ltd</pub><doi>10.1185/030079904X1980</doi></addata></record>
fulltext fulltext
identifier ISSN: 0300-7995
ispartof Current medical research and opinion, 2004, Vol.20 (S1), p.S5-S26
issn 0300-7995
1473-4877
language eng
recordid cdi_informahealthcare_journals_10_1185_030079904X1980
source Taylor & Francis; Taylor & Francis Medical Library - CRKN
subjects Complications
Cost-effectiveness
Costs
Diabetes
Health economics
Modelling
title The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A29%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20CORE%20Diabetes%20Model:%20Projecting%20Long-term%20Clinical%20Outcomes,%20Costs%20and%20Costeffectiveness%20of%20Interventions%20in%20Diabetes%20Mellitus%20(Types%201%20and%202)%20to%20Support%20Clinical%20and%20Reimbursement%20Decision-making&rft.jtitle=Current%20medical%20research%20and%20opinion&rft.au=Palmer,%20Andrew%20J.&rft.date=2004&rft.volume=20&rft.issue=S1&rft.spage=S5&rft.epage=S26&rft.pages=S5-S26&rft.issn=0300-7995&rft.eissn=1473-4877&rft_id=info:doi/10.1185/030079904X1980&rft_dat=%3Cinformahealthcare_cross%3E10_1185_030079904X1980%3C/informahealthcare_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true